The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
From off-period dystonia to peak-dose chorea: The clinical spectrum of varying subthalamic nucleus activity
Open accessAbstract
The effect of chronic bilateral high-frequency stimulation of the subthalamic nucleus (STN) on levodopa-induced dyskinaesias was investigated in eight patients with fluctuating Parkinson's disease complicated by functionally disabling off-period dystonia. All of the patients also had severe diphasic and peak-dose chorea, so that it was possible to study the effect of high-frequency stimulation on the different types of levodopa-induced dyskinaesias. Off-period fixed dystonia was reduced by 90% and off-period pain by 66%. After acute levodopa challenge, high-frequency stimulation of the STN reduced diphasic mobile dystonia by 50% and peak-dose choreic dyskinaesias by 30%. The effect of bilateral high-frequency stimulation of the STN on the Unified Parkinson's Disease Rating Scale motor score had the same magnitude as the preoperative effect of levodopa. This allowed the levodopa dose to be reduced by 47%. The combination of reduced medication and continuous high-frequency stimulation of the STN reduced the duration of on-period diphasic and peak-dose dyskinaesias by 52% and the intensity by 68%. Acute high-frequency stimulation of the STN mimics an acute levodopa challenge, concerning both parkinsonism and dyskinaesias, and suppresses off-period dystonia. Increasing the voltage can induce repetitive dystonic dyskinaesias, mimicking diphasic levodopa-induced dyskinaesias. A further increase in voltage leads to a shift from a diphasic-pattern dystonia to a peak-dose pattern choreodystonia. Chronic high-frequency stimulation of the STN also mimics the benefit of levodopa on parkinsonism and improves all kinds of levodopa-induced dyskinaesias to varying degrees. Off-period dystonia, associated with neuronal hyperactivity in the STN is directly affected by stimulation and disappears immediately. The effect of chronic high-frequency stimulation of the STN on diphasic and peak-dose dyskinaesias is more complex and is related directly to the functional inhibition of the STN and indirectly to the replacement of the pulsatile dopaminergic stimulation by continuous functional inhibition of the STN. Chronic high-frequency stimulation of the STN allows a very gradual increase in stimulation parameters with increasing beneficial effect on parkinsonism while reducing the threshold for the elicitation of stimulation-induced dyskinaesias. In parallel with improvement of parkinsonism, the levodopa dose can be gradually decreased. As diphasic dystonic dyskinaesias are improved to a greater degree than peak-dose dyskinaesias, both direct and indirect mechanisms may be involved. Peak-dose choreatic dyskinaesias, associated with little evidence of parkinsonism and thus with low neuronal activity in the STN, are improved, mostly indirectly. Fixed off-period dystonia, mobile diphasic dystonia and peak-dose choreodystonia seem to represent a continuous clinical spectrum reflecting a continuous spectrum of underlying activity patterns of STN neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus
Benabid, A. L., Pollak, P., Hoffmann, D., Gervason, C., Hommel, M., Perret, J. E., de Rougemont, J., & Gao, D. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)91175-t · Cited by 1,787
Self-citationDystonia in parkinson's disease: Clinical and pharmacological features
Poewe, W. H., Lees, A. J., & Stern, G. M. (1988) · Annals of Neurology · doi:10.1002/ana.410230112 · Cited by 162
The Pharmacology of Foot Dystonia in Parkinsonism
Poewe, W. H., & Lees, A. J. (1987) · Clinical Neuropharmacology · doi:10.1097/00002826-198702000-00004 · Cited by 28
Cited by
Krack, P., Batir, A., Van Blercom, N., Chabardes, S., Fraix, V., Ardouin, C., Koudsie, A., Limousin, P. D., Benazzouz, A., LeBas, J. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035275 · Cited by 2,249
Self-citationDeep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease
Benabid, A. L., Chabardes, S., Mitrofanis, J., & Pollak, P. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70291-6 · Cited by 1,285
A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor
Schuurman, P. R., Bosch, D. A., Bossuyt, P. M. M., Bonsel, G. J., van Someren, E. J. W., de Bie, R. M. A., Merkus, M. P., & Speelman, J. D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002173420703 · Cited by 1,044
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Thobois, S., Ardouin, C., Lhommee, E., Klinger, H., Lagrange, C., Xie, J., Fraix, V., Coelho Braga, M. C., Hassani, R., Kistner, A., et al. (2010) · Brain · doi:10.1093/brain/awq032 · Cited by 516
Self-citationStarr, P. A., Christine, C. W., Theodosopoulos, P. V., Lindsey, N., Byrd, D., Mosley, A., & Marks, W. J. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.97.2.0370 · Cited by 415
Deep brain stimulation: Neuropsychological and neuropsychiatric issues
Voon, V., Kubu, C., Krack, P., Houeto, J.-L., & Tröster, A. I. (2006) · Movement Disorders · doi:10.1002/mds.20963 · Cited by 403
Self-citationLevodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts
Espay, A. J., Morgante, F., Merola, A., Fasano, A., Marsili, L., Fox, S. H., Bezard, E., Picconi, B., Calabresi, P., & Lang, A. E. (2018) · Annals of Neurology · doi:10.1002/ana.25364 · Cited by 340
Mood and behavioural effects of subthalamic stimulation in Parkinson's disease
Castrioto, A., Lhommée, E., Moro, E., & Krack, P. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70294-1 · Cited by 333
Self-citationDeep brain stimulation: Postoperative issues
Deuschl, G., Herzog, J., Kleiner-Fisman, G., Kubu, C., Lozano, A. M., Lyons, K. E., Rodriguez-Oroz, M. C., Tamma, F., Tröster, A. I., Vitek, J. L., et al. (2006) · Movement Disorders · doi:10.1002/mds.20957 · Cited by 313
Deep brain stimulation: Preoperative issues
Lang, A. E., Houeto, J.-L., Krack, P., Kubu, C., Lyons, K. E., Moro, E., Ondo, W., Pahwa, R., Poewe, W., Tröster, A. I., et al. (2006) · Movement Disorders · doi:10.1002/mds.20955 · Cited by 308
Self-citationSubthalamic stimulation in Parkinson’s disease: restoring the balance of motivated behaviours
Lhommée, E., Klinger, H., Thobois, S., Schmitt, E., Ardouin, C., Bichon, A., Kistner, A., Fraix, V., Xie, J., Aya Kombo, M., et al. (2012) · Brain · doi:10.1093/brain/aws078 · Cited by 296
Self-citationSaint-Cyr, J. A., Hoque, T., Pereira, L. C. M., Dostrovsky, J. O., Hutchison, W. D., Mikulis, D. J., Abosch, A., Sime, E., Lang, A. E., & Lozano, A. M. (2002) · Journal of Neurosurgery · doi:10.3171/jns.2002.97.5.1152 · Cited by 291
Forced, not voluntary, exercise improves motor function in Parkinson's disease patients
Ridgel, A. L., Vitek, J. L., & Alberts, J. L. (2009) · Neurorehabilitation and neural repair · doi:10.1177/1545968308328726 · Cited by 284
“The levodopa equivalent daily dose (LEDD) was calculated for each patient, as described previously.(12) All subjects provided informed consent, following Cleveland Clinic IRB policy, prior to randomization.”
MethodReview: Deep brain stimulation in Parkinson’s disease
Groiss, S. J., Wojtecki, L., Südmeyer, M., & Schnitzler, A. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609339382 · Cited by 280
Breit, S., Schulz, J. B., & Benabid, A.-L. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0936-0 · Cited by 273
Clinical spectrum of levodopa‐induced complications
Aquino, C. C., & Fox, S. H. (2015) · Movement Disorders · doi:10.1002/mds.26125 · Cited by 270
Postoperative management of subthalamic nucleus stimulation for Parkinson's disease
Krack, P., Fraix, V., Mendes, A., Benabid, A.-L., & Pollak, P. (2002) · Movement Disorders · doi:10.1002/mds.10163 · Cited by 267
Self-citationFunkiewiez, A., Ardouin, C., Krack, P., Fraix, V., Van Blercom, N., Xie, J., Moro, E., Benabid, A., & Pollak, P. (2003) · Movement Disorders · doi:10.1002/mds.10441 · Cited by 264
Self-citationPathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
Ardouin, C., Voon, V., Worbe, Y., Abouazar, N., Czernecki, V., Hosseini, H., Pelissolo, A., Moro, E., Lhommée, E., Lang, A. E., et al. (2006) · Movement Disorders · doi:10.1002/mds.21098 · Cited by 261
Self-citationDystonia in Parkinson’s disease
Tolosa, E., & Compta, Y. (2006) · Journal of Neurology · doi:10.1007/s00415-006-7003-6 · Cited by 176
Jankovic, J., & Tintner, R. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(01)00025-6 · Cited by 135
Metadata
- Authors
- Krack, P.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-06-01
- Volume
- 122
- Issue
- 6
- Pages
- 1133-1146
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2004153344
- Cited by
- 229
- References
- 3
- FWCI
- 9.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.